Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology Debt to Equity Ratio 2010-2025 | POAI

Current and historical debt to equity ratio values for Predictive Oncology (POAI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Predictive Oncology debt/equity for the three months ending March 31, 2025 was 0.00.
  
Predictive Oncology Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.01B $0.00B -41.25
2024-12-31 $0.01B $0.00B -25.54
2024-09-30 $0.01B $0.00B 2.81
2024-06-30 $0.01B $0.00B 1.59
2024-03-31 $0.01B $0.00B 1.62
2023-12-31 $0.01B $0.01B 0.74
2023-09-30 $0.01B $0.01B 0.56
2023-06-30 $0.01B $0.02B 0.43
2023-03-31 $0.01B $0.02B 0.35
2022-12-31 $0.00B $0.02B 0.18
2022-09-30 $0.00B $0.03B 0.12
2022-06-30 $0.00B $0.03B 0.09
2022-03-31 $0.00B $0.04B 0.08
2021-12-31 $0.00B $0.04B 0.09
2021-09-30 $0.00B $0.05B 0.07
2021-06-30 $0.00B $0.05B 0.07
2021-03-31 $0.00B $0.04B 0.12
2020-12-31 $0.01B $0.00B 3.94
2020-09-30 $0.01B $0.01B 1.06
2020-06-30 $0.02B $0.01B 1.35
2020-03-31 $0.02B $0.01B 1.42
2019-12-31 $0.01B $0.01B 0.99
2019-09-30 $0.01B $0.02B 0.54
2019-06-30 $0.01B $0.02B 0.45
2019-03-31 $0.01B $0.00B 71.67
2018-12-31 $0.00B $0.00B 68.33
2018-09-30 $0.00B $0.00B 0.79
2018-06-30 $0.00B $0.00B 0.19
2018-03-31 $0.00B $0.01B 0.15
2017-12-31 $0.00B $0.00B 0.35
2017-09-30 $0.00B $0.00B 0.53
2017-06-30 $0.00B $0.00B 0.42
2017-03-31 $0.00B $0.00B 0.37
2016-12-31 $0.00B $0.00B 2.04
2016-09-30 $0.00B $0.00B 165.70
2016-06-30 $0.00B $0.00B 2.69
2016-03-31 $0.00B $0.00B 0.60
2015-12-31 $0.00B $0.00B 0.37
2015-09-30 $0.00B $0.01B 0.45
2015-06-30 $0.01B $-0.01B -1.12
2015-03-31 $0.01B $-0.01B -1.13
2014-12-31 $0.01B $-0.01B -1.16
2014-09-30 $0.01B $0.00B -1.32
2014-06-30 $0.00B $0.00B -1.30
2014-03-31 $0.00B $0.00B -1.60
2013-12-31 $0.00B $0.00B -1.18
2013-09-30 $0.00B $0.00B -1.53
2013-06-30 $0.00B $0.00B -1.13
2013-03-31 $0.00B $0.00B -1.29
2012-12-31 $0.00B $0.00B -1.11
2012-09-30 $0.00B $0.00B -1.20
2012-06-30 $0.00B $0.00B -1.17
2012-03-31 $0.00B $0.00B -1.12
2011-12-31 $0.00B $0.00B -1.17
2011-09-30 $0.00B $0.00B -1.11
2011-06-30 $0.00B $0.00B -1.10
2011-03-31 $0.00B $0.00B -1.22
2010-12-31 $0.00B $0.00B -1.08
2010-09-30 $0.00B $0.00B -1.09
2010-06-30 $0.00B $0.00B -1.10
2010-03-31 $0.00B $0.00B -1.11
2009-12-31 $0.00B $0.00B -1.12
2009-09-30 $0.00B $0.00B -1.18
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.008B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.064B 58.60
Hims & Hers Health (HIMS) United States $13.260B 137.77
Tempus AI (TEM) United States $12.137B 0.00
IRhythm Technologies (IRTC) United States $4.628B 0.00
Inspire Medical Systems (INSP) United States $3.753B 58.64
Hinge Health (HNGE) United States $2.965B 0.00
Privia Health (PRVA) United States $2.730B 186.58
Enovis (ENOV) United States $1.764B 9.83
Schrodinger (SDGR) United States $1.532B 0.00
Phreesia (PHR) United States $1.519B 0.00
Clover Health Investments (CLOV) United States $1.440B 0.00
Azenta (AZTA) United States $1.342B 62.36
Omnicell (OMCL) United States $1.335B 23.55
10x Genomics (TXG) United States $1.300B 0.00
Claritev (CTEV) United States $0.661B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Butterfly Network (BFLY) United States $0.544B 0.00
Talkspace (TALK) United States $0.477B 142.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.348B 771.33
Outset Medical (OM) United States $0.336B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
American Well (AMWL) United States $0.104B 0.00
CareCloud (CCLD) United States $0.099B 3.79
MDxHealth SA (MDXH) Belgium $0.093B 0.00
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.043B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00